• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número4"

Copied!
6
0
0

Texto

Loading

Imagem

Table 1 – Features of patients and treatment.
Figure 1 – Cumulative incidence of neutrophil engraftment over time.
Figure 3 – Cumulative incidence of acute graft-versus-host disease over time.
Figure 4 – Cumulative incidence of relapse over time.

Referências

Documentos relacionados

Different sources of stem cells (and maybe different types): bone marrow, peripheral blood or cord blood stem cells, and different techniques of transplantation are used..

Philadelphia chromosome-positive acute lymphoblastic leukemia rescued with a second allogeneic stem cell transplantation from a haploidentical mother after relapse following cord

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Eapen

positive precursor B-cell acute lymphoblastic leukemia with positive minimal residual disease (0.32%) before conditioning treatment for hematopoietic stem cell transplantation..

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.. Biol Blood

Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units. Improving quality and potency testing

According to the decree, the allogeneic hematopoietic stem cell transplantation (HSCT) with related donor, of bone marrow, peripheral blood or umbilical cord blood,

Although correlation between total nucle- ated cell and CD34+ cells in HUCB has been reported, within groups of samples with simi- lar total nucleated cell counts a high degree